alexa Use Of Bevacizumab As An Additional Strategy In Angle Closure Glaucoma ? Case Report | 6803
ISSN: 2161-1076

Surgery: Current Research
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Use of bevacizumab as an additional strategy in angle closure glaucoma ? case report

International Conference and Exhibition on Surgery, Anesthesia & Trichology

Joanna Liput and Iwona Helemejko

Accepted Abstracts: Surgery Curr Res

DOI: 10.4172/2161-1076.S1.010

We report the use of bevacizumab (Avastin) as an additional strategy in angle closure glaucoma based on the case of 47 years old male qualified to cataract removal as anti-glaucoma procedure in whom we observed iris and lens neovascularization. As a first step we administered 1.25 mg of bevacizumab into the anterior chamber. Iris as well as lens neovasularization completely disappeared 48 hours later. Finally after lens removal we achieved deeper anterior chamber, reduction and stabilization of intraocular pressure without necessity of hipotensive agent?s administration and improvement of visual acuity.
Joanna Liput has completed postdoctoral studies and her Ph.D at the age of 29 years from Wroclaw Medical University, Poland. She has published more than 25 papers in national and international journals. In 2006 granted by European Board of Ophthalmology. Currently works at Great Western Hospital in Swindon, UK.
Leave Your Message 24x7